BioNTech SE (NASDAQ: BNTX) reported Q3 EPS of (EUR0.12), EUR0.22 worse than the analyst estimate of EUR0.10. Revenue for the quarter came in at EUR1.52 billion versus the consensus estimate of EUR1.01 billion.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR2.6-2.8 billion, versus the consensus of EUR2.41 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.